Saturday 17 October 2026
Export MVIS’s income statement to Excel — free account
Microvision, Inc.
MVIS Technology Scientific & Technical Instruments
Microvision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 million, down 74.3% from fiscal 2024. In the quarter to June 2026, revenue grew 850.3%, EPS fell 84.5%, free cash flow fell 50.3% and total debt fell 43.3%, each against the same quarter a year earlier.
1.15
0.08
−6.50%
Follow MVIS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
38.43 | 127.18 | 187.76 | 139.11 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(5.76) | (12.02) | (14.72) | (22.23) | |
P/B ratio |
5.35 | 5.00 | 4.08 | 4.04 | |
Price to Tangible BV |
33.88 | 8.90 | 4.09 | 4.56 | |
EV/Sales |
28.80 | 97.21 | 125.43 | 101.24 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(1.23) | (2.47) | (2.58) | (4.57) | |
EV/FCF |
(1.21) | (2.44) | (2.55) | (4.53) | |
Quick Ratio |
0.57 | 0.91 | 2.50 | 2.50 | |
Current Ratio |
0.68 | 1.05 | 2.69 | 2.88 | |
Net Debt/EBITDA |
1.76 | 2.53 | 2.75 | 10.93 | |
Debt/Assets |
0.02% | 0.02% | 0.03% | 0.02% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.03 | 0.01 | 0.01 | 0.02 | |
Operating CF/Net income |
0.52 | 0.65 | 0.41 | 1.16 | |
Capex/Depreciation |
(0.04) | (0.03) | (0.02) | (0.04) | |
Interest Coverage |
(4.42) | (8.53) | (32.84) | (5.79) | |
Research and Development Expense of Revenue |
1,065.99% | 1,544.92% | 3,892.83% | 3,310.37% | |
Selling, General and Administrative Expense of Revenue |
625.32% | 1,017.22% | 1,428.25% | 1,670.95% | |
Intangible Assets out of Total Assets |
0.20 | 0.16 | 0.00 | 0.07 | |
Share Based Compensation of Revenue |
88.53% | 105.13% | (693.72%) | (665.15%) | |
Graham Net Nets |
(0.31) | (0.08) | 0.15 | 0.15 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(109.25%) | (48.41%) | (42.15%) | (29.82%) | |
Free Cash Flow Yield |
(61.89%) | (31.26%) | (26.19%) | (16.07%) | |
Revenue per Share |
0.07 | 0.05 | 0.01 | 0.01 | |
Operating CF per Share |
(0.86) | (0.80) | (0.85) | (0.84) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
(0.87) | (0.81) | (0.86) | (0.84) | |
Cash per Share |
1.24 | 2.26 | 4.13 | 5.07 | |
Shareholders Equity per Share |
0.92 | 1.92 | 3.05 | 4.60 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.92 | 1.92 | 3.05 | 4.60 | |
Free Cash Flow |
(19.45) | (16.59) | (15.65) | (16.62) | |
Working Capital |
(16.14) | 2.46 | 50.96 | 75.08 | |
Capital Expenditures |
(0.30) | (0.14) | (0.24) | (0.13) | |
Net Current Asset Value |
(33.70) | (16.44) | 33.54 | 54.87 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.21 | 0.15 | 1.09 | 0.53 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.51 | 0.49 | 0.49 | 0.14 | |
Average Payables |
3.72 | 2.90 | 1.38 | 1.41 | |
Average Inventory |
4.89 | 3.28 | 1.52 | 6.31 | |
Average Assets |
114.61 | 113.47 | 112.14 | 119.54 | |
Average Common Equity |
48.86 | 46.37 | 52.16 | 78.29 |
Columns are period end dates